"DMC Sinai-Grace Hospital draws on the traditions of two community hospitals and combines that history with the strength of a large medical system - The Detroit Medical Center (DMC). The hospital today continues to have deep roots in the community, providing compassionate, personal care backed by advanced medical treatments available locally and throughout the DMC."

During the past decade, Wayne State University - Sinai Grace Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wayne State University - Sinai Grace Hospital" #1 sponsor was "BrainScope Company, Inc." with 4 trials, followed by "Atox Bio Ltd" with 1 trials sponsored, "Banyan Biomarkers, Inc" with 1 trials sponsored, "Emergent BioSolutions" with 1 trials sponsored and "RedHill Biopharma Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wayne State University - Sinai Grace Hospital" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wayne State University - Sinai Grace Hospital" are "Brain Injuries" (3 trials), "Closed Head Injury" (1 trials), "Concussion, Brain" (1 trials), "Craniocerebral Trauma" (1 trials) and "Fournier's Gangrene" (1 trials). Many other conditions were trialed in "Wayne State University - Sinai Grace Hospital" in a lesser frequency.

Most popular intervention types in "Wayne State University - Sinai Grace Hospital" are "Other" (4 trials), "Device" (3 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "BrainScope Ahead 200" (2 trials), "22-item CSI" (1 trials), "AB103 0.5 mg/kg" (1 trials), "Clinician Evaluation" (1 trials) and "EEG Recording" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wayne State University - Sinai Grace Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Wayne State University - Sinai Grace Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wayne State University - Sinai Grace Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wayne State University - Sinai Grace Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".